Literature DB >> 14592408

Association between serotonin transporter gene polymorphism and chronic fatigue syndrome.

Masaaki Narita1, Naoko Nishigami, Naoko Narita, Kouzi Yamaguti, Nobuo Okado, Yasuyoshi Watanabe, Hirohiko Kuratsune.   

Abstract

Interaction between the hypothalamo-pituitary-adrenal axis and the serotonergic system is thought to be disrupted in chronic fatigue syndrome (CFS) patients. We examined a serotonin transporter (5-HTT) gene promoter polymorphism, which affects the transcriptional efficiency of 5-HTT, in 78 CFS patients using PCR amplification of the blood genomic DNA. A significant increase of longer (L and XL) alleic variants was found in the CFS patients compared to the controls both by the genotype-wise and the allele-wise analyses (both p<0.05, by chi(2) test and Fisher's exact test). Attenuated concentration of extracellular serotonin due to longer variants may cause higher susceptibility to CFS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592408     DOI: 10.1016/j.bbrc.2003.09.207

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  A systematic review of the association between fatigue and genetic polymorphisms.

Authors:  Tengteng Wang; Jie Yin; Andrew H Miller; Canhua Xiao
Journal:  Brain Behav Immun       Date:  2017-01-12       Impact factor: 7.217

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

3.  A population-based twin study of functional somatic syndromes.

Authors:  K Kato; P F Sullivan; B Evengård; N L Pedersen
Journal:  Psychol Med       Date:  2008-06-26       Impact factor: 7.723

4.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

5.  Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases Data from a Long-Term Observation.

Authors:  Nasra Aboud; Fabian Depré; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2016-10-18       Impact factor: 3.747

Review 6.  Testicular cancer survivorship: research strategies and recommendations.

Authors:  Lois B Travis; Clair Beard; James M Allan; Alv A Dahl; Darren R Feldman; Jan Oldenburg; Gedske Daugaard; Jennifer L Kelly; M Eileen Dolan; Robyn Hannigan; Louis S Constine; Kevin C Oeffinger; Paul Okunieff; Greg Armstrong; David Wiljer; Robert C Miller; Jourik A Gietema; Flora E van Leeuwen; Jacqueline P Williams; Craig R Nichols; Lawrence H Einhorn; Sophie D Fossa
Journal:  J Natl Cancer Inst       Date:  2010-06-28       Impact factor: 13.506

7.  Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

Authors:  Jasmine Eshragh; Anand Dhruva; Steven M Paul; Bruce A Cooper; Judy Mastick; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2016-10-05       Impact factor: 3.612

8.  Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.

Authors:  S J Bull; P Huezo-Diaz; E B Binder; J F Cubells; G Ranjith; C Maddock; C Miyazaki; N Alexander; M Hotopf; A J Cleare; S Norris; E Cassidy; K J Aitchison; A H Miller; C M Pariante
Journal:  Mol Psychiatry       Date:  2008-05-06       Impact factor: 15.992

9.  The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients.

Authors:  Nobue Shishioh-Ikejima; Tokiko Ogawa; Kouzi Yamaguti; Yasuyoshi Watanabe; Hirohiko Kuratsune; Hiroshi Kiyama
Journal:  BMC Neurol       Date:  2010-08-23       Impact factor: 2.474

Review 10.  Myalgic encephalomyelitis: International Consensus Criteria.

Authors:  B M Carruthers; M I van de Sande; K L De Meirleir; N G Klimas; G Broderick; T Mitchell; D Staines; A C P Powles; N Speight; R Vallings; L Bateman; B Baumgarten-Austrheim; D S Bell; N Carlo-Stella; J Chia; A Darragh; D Jo; D Lewis; A R Light; S Marshall-Gradisnik; I Mena; J A Mikovits; K Miwa; M Murovska; M L Pall; S Stevens
Journal:  J Intern Med       Date:  2011-08-22       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.